BiVictriX Therapeutics (BVX) Stock Chart & Stock Price History → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free BVX Stock Alerts GBX 11.50 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades BiVictriX Therapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance+2.22%3 Month PerformanceN/A6 Month Performance-11.54%Year-To-Date PerformanceN/A1 Year Performance-20.69% Receive BVX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BiVictriX Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy BVX Stock Chart for Sunday, April, 28, 2024 BVX Chart by TradingView BiVictriX Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024GBX 11.50GBX 11.50GBX 11.68GBX 11.50428 shs£9.49 million04/25/2024GBX 11.50GBX 11.50GBX 11.68GBX 11.50428 shs£9.49 million04/24/2024GBX 11.50GBX 11.50GBX 11.68GBX 11.50428 shs£9.49 million04/23/2024GBX 11.50GBX 11.50GBX 11.68GBX 11.50428 shs£9.49 million04/22/2024GBX 11.50GBX 11.50GBX 11.68GBX 11.50428 shs£9.49 million04/19/2024GBX 11GBX 11.50+4.55%GBX 11.50GBX 11188,757 shs£9.49 million Get the Latest News and Ratings for BVX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BiVictriX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024GBX 11.54GBX 11-4.68%GBX 11.03GBX 11188,757 shs£9.08 million04/17/2024GBX 11.25GBX 11.54+2.58%GBX 11.54GBX 11.5420,000 shs£9.52 million04/16/2024GBX 10.52GBX 11.25+6.99%GBX 11.25GBX 11.252,021 shs£9.29 million04/15/2024GBX 11.25GBX 10.52-6.53%GBX 11.25GBX 10.522,021 shs£8.68 million04/12/2024GBX 11.25GBX 10.52-6.53%GBX 10.52GBX 10.522,023 shs£8.68 million04/10/2024GBX 11.25GBX 11.25GBX 11.25GBX 11.2510,000 shs£9.29 million04/09/2024GBX 10.51GBX 11.25+7.04%GBX 11.25GBX 10.5110,000 shs£9.29 million04/08/2024GBX 10.51GBX 10.51GBX 11.25GBX 10.5110,000 shs£8.67 million04/05/2024GBX 11.87GBX 10.51-11.46%GBX 10.51GBX 10.5110,000 shs£8.67 million04/04/2024GBX 11.50GBX 11.87+3.22%GBX 11.90GBX 10.50198,003 shs£9.80 million04/03/2024GBX 11.25GBX 11.50+2.22%GBX 11.50GBX 11.5025,983 shs£9.49 million04/01/2024GBX 11.25GBX 11.25GBX 11.55GBX 10.5014,569 shs£9.29 million03/29/2024GBX 11.25GBX 11.25GBX 11.55GBX 10.5014,569 shs£9.29 million03/28/2024GBX 11.75GBX 11.25-4.26%GBX 11.55GBX 10.5014,569 shs£9.29 million03/27/2024GBX 11.75GBX 11.75GBX 11.75GBX 11.759,000 shs£9.70 million03/26/2024GBX 11.75GBX 11.75GBX 11.75GBX 11.609,000 shs£9.70 million03/25/2024GBX 11.75GBX 11.75GBX 11.75GBX 11.609,000 shs£9.70 million03/22/2024GBX 12GBX 11.51-4.12%GBX 11.51GBX 11.5110,000 shs£9.50 million03/21/2024GBX 11.75GBX 12+2.13%GBX 12GBX 11.50253 shs£9.90 million03/20/2024GBX 11.55GBX 11.75+1.73%GBX 11.75GBX 11.555,000 shs£9.70 million03/19/2024GBX 11.87GBX 11.55-2.70%GBX 11.55GBX 11.555,000 shs£9.53 million03/18/2024GBX 11.87GBX 11.87GBX 11.87GBX 11.75750 shs£9.80 million03/15/2024GBX 11.75GBX 11.87+1.02%GBX 11.87GBX 11.87752 shs£9.80 million03/12/2024GBX 11.50GBX 11.75+2.17%GBX 11.75GBX 11.75100 shs£9.70 million03/11/2024GBX 11.75GBX 11.50-2.13%GBX 11.75GBX 11.50100 shs£9.49 million03/08/2024GBX 11.50GBX 11.75+2.17%GBX 11.87GBX 11.5018,134 shs£9.70 million03/07/2024GBX 11.60GBX 11.50-0.86%GBX 11.50GBX 11.509 shs£9.49 million03/06/2024GBX 11.75GBX 11.60-1.28%GBX 11.87GBX 11.5018,134 shs£9.57 million03/05/2024GBX 11.50GBX 11.75+2.17%GBX 11.75GBX 11.5981,065 shs£9.70 million03/04/2024GBX 11.50GBX 11.50GBX 11.50GBX 11.05789 shs£9.49 million03/01/2024GBX 11.50GBX 11.50GBX 11.50GBX 11.50789 shs£9.49 million02/29/2024GBX 11.05GBX 11.50+4.07%GBX 11.50GBX 11.05789 shs£9.49 million02/28/2024GBX 11.50GBX 11.05-3.91%GBX 11.05GBX 11.05789 shs£9.12 million02/12/2024GBX 11.50GBX 11.50GBX 11.50GBX 11.5012,154 shs£9.49 millionConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.02/09/2024GBX 11.50GBX 11.50GBX 11.50GBX 11.5012,154 shs£9.49 million02/08/2024GBX 11.50GBX 11.50GBX 11.50GBX 11.5012,154 shs£9.49 million02/07/2024GBX 12GBX 11.50-4.17%GBX 12GBX 11.50100 shs£9.49 million02/06/2024GBX 11.05GBX 12+8.60%GBX 12GBX 1212 shs£9.90 million02/05/2024GBX 11.50GBX 11.05-3.91%GBX 11.59GBX 11.0512,154 shs£9.12 million02/02/2024GBX 11.50GBX 11.50GBX 11.59GBX 11.50173 shs£9.49 million02/01/2024GBX 11.50GBX 11.50GBX 11.59GBX 11.50173 shs£9.49 million01/31/2024GBX 11.50GBX 11.50GBX 12.20GBX 11.50260 shs£9.49 million01/30/2024GBX 11.50GBX 11.50GBX 12GBX 11120,024 shs£9.49 million Related Companies: ImmuPharma Stock Chart Roquefort Therapeutics Stock Chart Genflow Biosciences Stock Chart BSF Enterprise Stock Chart Synairgen Stock Chart ValiRx Stock Chart IXICO Stock Chart NetScientific Stock Chart Oxford Cannabinoid Technologies Stock Chart Ondine Biomedical Stock Chart Receive BVX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BiVictriX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BVX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryWhy Big Pharma is Investing Billions in This BiotechBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiVictriX Therapeutics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.